atai Life Sciences to Announce Second Quarter 2022 Financial Results and...

BREAKING: Morgan Stanley Publishes Optimistic Report on Psychedelics

Algernon Pharmaceuticals Reports Additional Positive Data From its Phase 2 Study...

FILAMENT HEALTH ANNOUNCES PARTICIPATION IN PROJECT SOLACE

PT342 – Spencer Hawkswell – The Right to Psilocybin in Canada:...

Psychedelic Bulletin #112 – Inside the DEA Challenge; Second Psychedelics Company...

Inside the Challenge to DEA’s Proposed Scheduling of 5 Psychedelic Tryptamines

COMPASS Pathways launches phase II clinical trial of psilocybin therapy in...

Silo Pharma Announces Positive Results from its Topically Administered Formulation of...

Incannex Healthcare Quarterly Activities Report and Appendix 4C Cash Flow Statement

1...160161162...307Page 161 of 307